|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
Lawson Health Research Institute Biomet, Inc. |
| Information provided by: | Lawson Health Research Institute |
| ClinicalTrials.gov Identifier: | NCT00517452 |
Purpose
The use of platelet rich plasma will decrease wound infection postop.
| Condition | Phase |
|
Atherosclerosis |
Phase II Phase III |
| Study Type: | Observational |
| Study Design: | Natural History, Longitudinal, Defined Population, Prospective Study |
| Official Title: | Phase 2-3 Observational Wound Care Study Comparing Application of Platelet Rich Plasma With Standard of Care Wound Closure in Vascular Patients Requiring a Groin Incision. |
Eligibility
| Ages Eligible for Study: | 35 Years to 90 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Contacts and Locations
More Information
| Study ID Numbers: | R-07-098 |
| First Received: | August 16, 2007 |
| Last Updated: | August 16, 2007 |
| ClinicalTrials.gov Identifier: | NCT00517452 |
| Health Authority: | Canada: Health Canada |
|
|